Drug therapy for chronic musculoskeletal pain syndromes: the concept of adjuvant analgesics and the prospect of its implementation
https://doi.org/10.14412/2074-2711-2020-1-105-111
Abstract
Treatment for pain syndromes is one of the most relevant areas of modern medicine, which is of high social, economic and, individual importance. One of the most difficult questions is therapy for chronic pain (CP). This therapy should be based on a thorough analysis of the causes of pain. It is necessary to use combinations of drugs that potentiate the analgesic effects of each other and have a low risk of complications. The concept of adjuvant analgesics as one of the promising areas of treatment for chronic kidney disease is discussed.
Keywords
chronic pain,
co-analgesics,
nonsteroidal anti-inflammatory drugs,
vitamin B group,
chondroprotectors, muscle relaxants
Supporting agencies: Публикация статьи поддержана ООО «Верваг Фарма».
About the Authors
S. A. Zhivolupov
Department of Nervous System Diseases, S.M. Kirov Military Medical Academy, Ministry of Defense of Russia
Russian Federation
6, Academician Lebedev St., Saint Petersburg 194044
Russian Federation
6, Academician Lebedev St., Saint Petersburg 194044
I. V. Litvinenko
Department of Nervous System Diseases, S.M. Kirov Military Medical Academy, Ministry of Defense of Russia
Russian Federation
6, Academician Lebedev St., Saint Petersburg 194044
Russian Federation
6, Academician Lebedev St., Saint Petersburg 194044
I. N. Samartsev
Department of Nervous System Diseases, S.M. Kirov Military Medical Academy, Ministry of Defense of Russia
Russian Federation
6, Academician Lebedev St., Saint Petersburg 194044
Russian Federation
6, Academician Lebedev St., Saint Petersburg 194044
N. A. Rashidov
Department of Nervous System Diseases, S.M. Kirov Military Medical Academy, Ministry of Defense of Russia
Russian Federation
6, Academician Lebedev St., Saint Petersburg 194044
Russian Federation
6, Academician Lebedev St., Saint Petersburg 194044
A. Yu. Kravchuk
Department of Nervous System Diseases, S.M. Kirov Military Medical Academy, Ministry of Defense of Russia
Russian Federation
6, Academician Lebedev St., Saint Petersburg 194044
Russian Federation
6, Academician Lebedev St., Saint Petersburg 194044
A. N. Barinov
Department of Nervous System Diseases and Neurosurgery; Research Department of Neurology, Science and Technology Park for Biomedicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation
11, Rossolimo St., Build. 1, Moscow 119021
Russian Federation
11, Rossolimo St., Build. 1, Moscow 119021
References
1. Treede R, Riel W, Barke A, et al. Chronic pain as a symptom or a disease: the IASP classification of chronic pain for the international classification of diseases (ICD-11). Pain. 2019 Jan;160(1):19-27. doi: 10.1097/j.pain.0000000000001384.
2. Davies M, Cohen S. Acute presentations of chronic pain conditions. In: Mahoney PF, Buckenmaier C, editors. Combat Anesthesia: The First 24 Hours (Textbooks of Military Medicine) Department of the Army; 2015. P. 245-59.
3. Shrestha R, Silwal P, Basnet N, et al. A prospective study of commonly prescribed drugs in the management of neuropathic. Pain and its Medication Adherence Pattern. Kathmandu Univ Med J (KUMJ). 2016 Jan-Mar;14(53):47-53.
4. Данилов АБ. Управление болью. Биопсихосоциальный подход. Москва: АММ-пресс; 2016. 636 с.
5. Oliveira CB, Maher CG, Pinto RZ. Clinical practice guidelines for the management of non-specific low back pain in primary care: an updated overview. Eur Spine J. 2018 Nov; 27(11):2791-2803. doi: 10.1007/s00586-018-5673-2. Epub 2018 Jul 3.
6. Sondergaard K, Gislason G. NSAIDs and cardiac arrest: Non-steroidal anti-inflammatory drug use is associated with increased risk of Out-of-hospital Cardiac Arrest: A nationwide Case-Time-Control study. Eur Heart J. 2017 Jun 14;38(23):1788-1789. doi: 10.1093/eurheartj/ehx267.
7. Lassen A, Hallas J, Schaffalitzky de Muckadell OB. Complicated and uncomplicated peptic ulcers in a Danish county 1993-2002: a population-based cohort study. Am J Gastroenterol. 2006 May;101(5):945-53.
8. Grosser T, Yu Y, Fitzgerald G. Emotion recollected in tranquility: lessons learned from the COX-2 saga. Annu Rev Med. 2010;61:17-33. doi: 10.1146/annurev-med-011209-153129.
9. Coxib and traditional NSAID Trialists' (CNT) Collaboration, Bhala N, Emberson J, Merhi A, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013 Aug 31;382(9894):769-79. doi: 10.1016/S0140-6736(13)60900-9. Epub 2013 May 30.
10. McGettigan P, Henry D. Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLoS Med. 2011 Sep;8(9):e1001098. doi: 10.1371/journal.pmed.1001098. Epub 2011 Sep 27.
11. Галанов ДВ. Рациональная комбинированная терапия болевых синдромов. Лечебное дело. 2013;(3):24-31.
12. Calderon-Ospina С, Nava-Mesa М, Arbelaez Ariza С. Еffect of combined diclofenac and В vitamins (thiamine, pyridoxine, and cyanocobalamin) for low back pain management: systematic review and metaanalysis. Pain Med. 2019 Sep 16. pii: pnz216. doi: 10.1093/pm/pnz216. [Epub ahead of print]
13. Okada H, Honda M, Ono H. Method for recording spinal reflexes in mice: effects of thyrotropinreleasing hormone, DOI, tolperisone and baclofen on monosynaptic spinal reflex potentials. Jpn J Pharmacol. 2001 May; 86(1):134-6.
14. Овчинникова ЕА, Рашид МА, Куликов АЮ. Эффективность, безопасность и фармакоэкономические аспекты применения толперизона. Практика. 2005; (1):1–9.
15. Пизова НВ. Мильгамма и Мильгамма Композитум при лечении неврологических заболеваний. Неврология, нейропсихиатрия, психосоматика. 2009;1(3-4):75-81. doi: 10.14412/2074-2711-2009-60
16. Левин ОС. Вертеброгенная поясничнокрестцовая радикулопатия: современные подходы к диагностике и лечению. Эффективная фармакотерапия. Неврология. 2015;23(3):40-48.
17. Deng XT, Han Y, Liu WT, Song XJ. B Vitamins potentiate acute morphine antinociception and attenuate the development of tolerance to chronic morphine in mice. Pain Med. 2017 Oct 1;18(10):1961-1974. doi: 10.1093/pm/pnw358.
18. Zhang M, Han W, Hu S, Xu H. Methylcobalamin: a potential vitamin of pain killer. Neural Plast. 2013;2013:424651. doi: 10.1155/2013/424651. Epub 2013 Dec 26.
19. Ponce-Monter HA, Ortiz MI, Garza-Hernandez AF. Effect of diclofenac with B vitamins on the treatment of acute pain originated by lower-limb fracture and urgery. Pain Res Treat. 2012;2012:104782. doi: 10.1155/2012/104782. Epub 2011 Oct 31.
20. Maga-na-Villa MC, Rocha-Gonzalez HI, Fernandez del Valle-Laisequilla C. B-vitamin mixture improves the analgesic effect of diclofenac in patients with osteoarthritis: A double blind study. Drug Res (Stuttg). 2013 Jun; 63(6):289-92. doi: 10.1055/s-0033-1334963. Epub 2013 Mar 22.
21. Kuhlwein A, Meyer HJ, Koehler CO. Reduced diclofenac administration by B vitamins: Results of a randomized double-blind study with reduced daily doses of diclofenac (75 mg diclofenac versus 75 mg diclofenac plus B vitamins) in acute lumbar vertebral syndromes. Klin Wochenschr. 1990 Jan 19;68(2): 107-15.
22. Vetter G, Bruggemann G, Lettko M. Shortening diclofenac therapy by B vitamins. Results of a randomized double-blind study, diclofenac 50 mg versus diclofenac 50 mg plus B vitamins, in painful spinal diseases with degenerative changes. Z Rheumatol. 1988 Sep-Oct; 47(5):351-62.
23. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Systematic Reviews in Health Care. New York: John Wiley & Sons; 2008. P. 285–312.
24. Mauro GL, Martorana U, Cataldo P, et al. Vitamin B in low back pain: A randomised, double-blind, placebo-controlled study. Eur Rev Med Pharmacol Sci. 2000 May-Jun;4(3):53-8.
25. Buesing S, Costa M, Schilling J. Vitamin B12 as a treatment for pain. Pain Physician. 2019 Jan;22(1):E45-E52.
26. Lettko M, Bartoszyk GD. Reduced need for diclofenac with concomitant administration of pyridoxine and other B vitamins. Ann N Y Acad Sci. 1990;585:510–2.
27. Khan TA, Ahmad A, Haider IZ. Low dose diclofenac sodium with vitamin-B complex compared with diclofenac alone. Professional Med J. 2008;15:440–4
28. Mibielli MA, Geller M, Cohen JC, et al. Diclofenac plus B vitamins versus diclofenac monotherapy in lumbago: the DOLOR study. Curr Med Res Opin. 2009 Nov;25(11):2589-99. doi: 10.3111/13696990903246911.
29. Gellera М, Mibiellia М, Nunesa С, et al. Comparison of the action of diclofenac alone versus diclofenac plus B vitamins on mobility in patients with low back pain. J Drug Assess. 2016 Mar 31;5(1):1-3. eCollection 2016.
30. Kамчатнов ПР. Повышение эффективности и безопасности лечения пациентов с поясничной болью. Журнал неврологии и психиатрии. 2016;(10):28-33. https://doi.org/10.17116/jnevro201611610128-33
31. Головачева ВА, Головачева АА. Терапия острой неспецифической боли в спине: новые возможности. Неврология, нейропсихиатрия, психосоматика. 2018;10(4):123–8. doi: Therapy for acute nonspecific back pain: new additional opportunities
32. Deng XT, Han Y, Liu WT, Song XJ. B Vitamins potentiate acute morphine antinociception and attenuate the development of tolerance to chronic morphine in mice. Pain Med. 2017 Oct 1;18(10):1961-1974. doi: 10.1093/pm/pnw358.
Review
For citations:
Zhivolupov SA, Litvinenko IV, Samartsev IN, Rashidov NA, Kravchuk AY, Barinov AN. Drug therapy for chronic musculoskeletal pain syndromes: the concept of adjuvant analgesics and the prospect of its implementation. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2020;12(1):105-111. (In Russ.) https://doi.org/10.14412/2074-2711-2020-1-105-111
Views:
922
Email this article 